Literature DB >> 19180699

Use of nebulized heparin in the treatment of smoke inhalation injury.

Perenlei Enkhbaatar1, David N Herndon, Daniel L Traber.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19180699     DOI： 10.1097/BCR.0b013e3181923bd3

Source DB:  PubMed          Journal:  J Burn Care Res        ISSN： 1559-047X            Impact factor:   1.845


× No keyword cloud information.
  6 in total

Review 1.  [Inhalation injury--epidemiology, diagnosis and therapy].

Authors:  Ulrich Thaler; Paul Kraincuk; Lars-Peter Kamolz; Manfred Frey; Philipp G H Metnitz
Journal:  Wien Klin Wochenschr       Date:  2010-01       Impact factor: 1.704

2.  Pathophysiology, management and treatment of smoke inhalation injury.

Authors:  Sebastian Rehberg; Marc O Maybauer; Perenlei Enkhbaatar; Dirk M Maybauer; Yusuke Yamamoto; Daniel L Traber
Journal:  Expert Rev Respir Med       Date:  2009-06-01       Impact factor: 3.772

3.  The Outcomes of Inhalation Injuries in Lesser Burns: Still a Deadly Injury.

Authors:  Salomon Puyana; Samuel Ruiz; Francisco Amador; Mark Mckenney; Elizabeth Young; Rizal Lim; Haaris Mir
Journal:  Eplasty       Date:  2021-09-29

Review 4.  Smoke Inhalation Injury: Etiopathogenesis, Diagnosis, and Management.

Authors:  Kapil Gupta; Mayank Mehrotra; Parul Kumar; Anoop Raj Gogia; Arun Prasad; Joseph Arnold Fisher
Journal:  Indian J Crit Care Med       Date:  2018-03

5.  Nebulized heparin for inhalation injury in burn patients: a systematic review and meta-analysis.

Authors:  Xiaodong Lan; Zhiyong Huang; Ziming Tan; Zhenjia Huang; Dehuai Wang; Yuesheng Huang
Journal:  Burns Trauma       Date:  2020-06-04

6.  HEPBURN - investigating the efficacy and safety of nebulized heparin versus placebo in burn patients with inhalation trauma: study protocol for a multi-center randomized controlled trial.

Authors:  Gerie J Glas; Johannes Muller; Jan M Binnekade; Berry Cleffken; Kirsten Colpaert; Barry Dixon; Nicole P Juffermans; Paul Knape; Marcel M Levi; Bert G Loef; David P Mackie; Manu Malbrain; Marcus J Schultz; Koenraad F van der Sluijs
Journal:  Trials       Date:  2014-03-25       Impact factor: 2.279
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.